Prophylactic Immediate Lymphatic Reconstruction for the Prevention of Secondary Lymphedema: A Systematic Review and Meta-Analysis of Comparative Studies
In brief
Immediate lymphatic reconstruction was linked to half the lymphedema rate
Across 17 comparative studies involving 2,261 patients, lymphedema occurred in 12.5% after immediate lymphatic reconstruction, versus 24.2% without it. The lower rates appeared similar after upper- and lower-limb procedures, but most evidence was observational, with study differences and possible publication bias limiting confidence; randomized trials are still needed to establish the true benefit.
- Journal
- Microsurgery (Q1)
- Published
- 1 October 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- T Read, R Arora, G Velli, A Ho, M Cheng, L Watson
- PMID
- 42803604
- DOI
- 10.1002/micr.70295
Why clinicians should know about it
- Picked for Epidemiology (paper of the day, 30 September 2026): Systematic review/meta‑analysis of prophylactic lymphatic reconstruction
Abstract
BACKGROUND: Secondary lymphedema remains a frequent and debilitating complication of axillary and inguinal lymph node dissection within oncological settings. Prophylactic lymphovenous shunting (LVS) delivered as immediate lymphatic reconstruction (ILR) has emerged as a strategy to preserve lymphatic continuity and reduce postoperative lymphedema. This systematic review and meta-analysis evaluated the effectiveness of prophylactic LVS across oncologic indications. METHODS: A comprehensive search of Medline (PubMed), Embase (Elsivier) and Cochrane Central databases identified comparative studies reporting lymphedema outcomes following prophylactic LVS performed at the time of nodal dissection. Seventeen studies met inclusion criteria, encompassing both upper- and lower-limb procedures. Primary outcome was incidence of clinically diagnosed lymphedema. A random-effects model was used to derive pooled effect estimates. Heterogeneity, subgroup analyses, and publication bias (including trim-and-fill adjustment) were assessed. RESULTS: Across 2261 patients, prophylactic ILR was associated with a significant reduction in postoperative lymphedema (100/800 [12.5%] vs. 353/1461 [24.2%]); (pooled OR 0.27; 95% CI 0.17-0.42; p < 0.01). Between-study heterogeneity was moderate (I2 = 52.8%; Q = 35.47 p < 0.01). Subgroup analysis demonstrated no significant difference in treatment effect between upper- and lower-limb procedures (Qm = 0.47; p = 0.49). Trim-and-fill adjustment suggested potential small-study effects; however, the protective association persisted following imputation (adjusted OR 0.37; p < 0.0001). Overall, the direction of effect across studies was consistent. CONCLUSIONS: Prophylactic LVS was associated with a lower incidence of lymphedema following axillary and inguinal lymph node dissection. However, confidence in the estimated treatment effect is limited by the predominance of observational evidence, methodological heterogeneity, and possible publication bias, highlighting the need for adequately powered multicenter randomized trials.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.